Literature DB >> 21881500

HDLs, immunity, and atherosclerosis.

Giuseppe D Norata1, Angela Pirillo, Alberico L Catapano.   

Abstract

PURPOSE OF REVIEW: HDLs possess several physiological activities that may explain their antiatherosclerotic properties. Among them, the most relevant is the ability of HDL to promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion. RECENT
FINDINGS: The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. HDL also acts as a reservoir for a number of biologically active substances that may impact the immune system, and as the HDL composition varies to a large extent during inflammation.
SUMMARY: The understanding of how these interactions take place and how biologically active substances can be delivered to relevant targets during atherogenesis is of great interest and may provide a better understanding for the role of HDL in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881500     DOI: 10.1097/MOL.0b013e32834adac3

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  17 in total

Review 1.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

Review 2.  HDL: to treat or not to treat?

Authors:  Angela Pirillo; Gianpaolo Tibolla; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

Review 3.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

Review 4.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

5.  Regulation of the cholesterol efflux transporters ABCA1 and ABCG1 in retina in hemochromatosis and by the endogenous siderophore 2,5-dihydroxybenzoic acid.

Authors:  Sudha Ananth; Jaya P Gnana-Prakasam; Yangzom D Bhutia; Rajalakshmi Veeranan-Karmegam; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochim Biophys Acta       Date:  2014-01-23

6.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13

Review 7.  MicroRNAs and lipoproteins: a connection beyond atherosclerosis?

Authors:  Giuseppe Danilo Norata; Federica Sala; Alberico Luigi Catapano; Carlos Fernández-Hernando
Journal:  Atherosclerosis       Date:  2012-11-24       Impact factor: 5.162

Review 8.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

9.  Plasma apolipoprotein O level increased in the patients with acute coronary syndrome.

Authors:  Bi-lian Yu; Chen-lu Wu; Shui-ping Zhao
Journal:  J Lipid Res       Date:  2012-06-12       Impact factor: 5.922

Review 10.  Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases.

Authors:  Fabrizia Bonacina; Andrea Baragetti; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Mediators Inflamm       Date:  2013-04-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.